May 12 (Reuters) - LabCorp said on Tuesday it has now made available its at-home sample collection kit for COVID-19 testing to all individuals with symptoms and possible exposure to the virus, after having limited delivery to healthcare workers last month.
The collection kit, launched in April with a list price of $119, comes with cotton swabs to collect nasal specimens, a biohazard specimen bag and a FedEx overnight shipping envelope to mail the samples to labs.
LabCorp said it has over 200,000 at-home collection kits and was prepared to significantly expand capacity as required.
At-home sample collection reduces the risk of transmitting the coronavirus to medical staff but has possible shortcomings, including whether a patient can collect the sample properly and ship it safely to the lab.
In addition to a COVID-19 lab test that was launched early in March, LabCorp offers an antibody blood test that can confirm whether the person has ever been infected with the virus. (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Ramakrishnan M.)